External reports (aggregated public sources), Value Investors Club

Value Investors Club

External reports (aggregated public sources)

Equity Bottom-Up

Quipt Home Medical Corp / Equity Bottom-Up

<ul><li>Quipt is the 5th largest home medical equipment provider in the US, specializing in respiratory equipment and consumables for patients in a home setting.</li><li>The company operates out of 125 locations in 26 states, with dual listings in Canada and the US.</li><li>Despite a 26% increase in share count and $70 million rise in debt, Quipt's stock price has fallen by 4% due to concerns about potential competition from GLP-1s and a Civil Investigative Demand regarding possible false claims to government healthcare programs.</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

Quipt is the 5th largest home medical equipment provider in the US, specializing in respiratory equipment and consumables for patients in a home setting.The company operates out of 125 locations in 26 states, with dual listings in Canada and the US.Despite a 26% increase in share count and $70 million rise in debt, Quipt's stock price has fallen by 4% due to concerns about potential competition from GLP-1s and a Civil Investigative Demand regarding possible false claims to government healthcare programs.This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Quipt Home Medical Corp (QIPT) - Wednesday, Mar 6, 2024

Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Capital Markets

Quipt Home Medical Corp / Equity Capital Markets

<ul><li>This is our first report on Quipt Home Medical and we look to provide a detailed account of the various drivers that will be responsible for the company’s growth in the coming years.</li><li>It is worth highlighting that Quipt Home Medical’s management team has 50+ years of mutual experience in healthcare administration as well as acquisitions.</li><li>Baptista Research looks to evaluate the different factors that could influence Quipt Home Medical’ price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology to determine a suitable price for the company’s stock.</li></ul>

This is our first report on Quipt Home Medical and we look to provide a detailed account of the various drivers that will be responsible for the company’s growth in the coming years.It is worth highlighting that Quipt Home Medical’s management team has 50+ years of mutual experience in healthcare administration as well as acquisitions.Baptista Research looks to evaluate the different factors that could influence Quipt Home Medical’ price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology to determine a suitable price for the company’s stock.

Quipt Home Medical Corp. - Investment Thesis

United States

Quipt Home Medical Corp. operates as healthcare services company. The Company specializes in home management of chronic illness through the application of telehealth systems. Quipt Home Medical serves patients and physicians in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Quipt Home Medical Corp (QIPT US)

Quipt Home Medical Corp (QIPT) - Wednesday, Mar 6, 2024

Quipt is the 5th largest home medical equipment provider in the US, specializing in respiratory equipment and consumables for patients in a home...

Value Investors Club

Quipt Home Medical Corp. - Investment Thesis

This is our first report on Quipt Home Medical and we look to provide a detailed account of the various drivers that will be responsible for the...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)